Radix Astragali extract promotes angiogenesis involving vascular endothelial growth factor receptor-related phosphatidylinositol 3-kinase/akt-dependent pathway in human endothelial cells

Phytotherapy Research

Volumn 23, Issue 9, 2009, Pages 1205-1213

  Zhang, Yi ^a   Hu, Guang ^a   Lin, Hui Chao ^a   Hong, Si Jia ^a   Deng, Yan Hui ^a   Tang, Jing Yan ^a   Sai, Wang Seto ^b   Kwan, Yiu Wa ^b   Waye, Mary Miu Yee ^b   Wang, Yi Tao ^a   Lee, Simon Ming Yuen ^a  

^a University of Macau   (Macao)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Akt; Angiogenesis; HUVEC; PI3K; Radix Astragali extract; VEGF

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; ISOFLAVONE DERIVATIVE; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PLANT EXTRACT; PROTEIN KINASE B; RADIX ASTRAGALI EXTRACT; SAPONIN; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CHINESE MEDICINE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN EXPRESSION; RADIX ASTRAGALI; UMBILICAL VEIN; WOUND HEALING;

CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; DRUGS, CHINESE HERBAL; ENDOTHELIAL CELLS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHATIDYLINOSITOL 3-KINASE; PROTO-ONCOGENE PROTEINS C-AKT; UMBILICAL VEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 69749109625     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2479     Document Type: Article

References (51)

1. Ahmad S, Hewett PW, Wang P et al. 2006. Direct evidence for endothelial vascular endothelial growth factor receptor-1 function in nitric oxide-mediated angiogenesis. Circ Res 99: 715-722. (Pubitemid 44498305)
2. Bocci G, Man S, Green SK et al. 2004. Increased plasma vascular endothelial growth factor (VEGF) as a surrogate marker for optimal therapeutic dosing of VEGF receptor-2 monoclonal antibodies. Cancer Res 64: 6616-6625. (Pubitemid 39297922)
3. Boo YC, Hwang J, Sykes M et al. 2002. Shear stress stimulates phosphorylation of eNOS at Ser(635) by a protein kinase A-dependent mechanism. Am J Physiol Heart Circ Physiol 283: H1819-H1828.
4. Cai J, Jiang WG, Ahmed A, Boulton M. 2006. Vascular endothelial growth factor-induced endothelial cell proliferation is regulated by interaction between VEGFR-2, SH-PTP1 and eNOS. Microvasc Res 71: 20-31. (Pubitemid 43175845)
5. Dimmeler S, Dernbach E, Zeiher AM. 2000. Phosphorylation of the endothelial nitric oxide synthase at ser-1177 is required for VEGF-induced endothelial cell migration. FEBS Lett 477: 258-262. (Pubitemid 30450177)
6. Dimmeler S, Zeiher AM. 1999. Nitric oxide - an endothelial cell survival factor. Cell Death Differ 6: 964-968. (Pubitemid 29520797)
7. Dong TT, Zhao KJ, Gao QT et al. 2006. Chemical and biological assessment of a Chinese herbal decoction containing Radix Astragali and Radix Angelicae Sinensis: Determination of drug ratio in having optimized properties. J Agric Food Chem 54: 2767-2774.
8. Fan TP, Yeh JC, Leung KW, Yue PY, Wong RN. 2006. Angiogenesis: from plants to blood vessels. Trends Pharmacol Sci 27: 297-309.
9. Fan Y, Wu DZ, Gong YQ, Zhou JY, Hu ZB. 2003. Effects of calycosin on the impairment of barrier function induced by hypoxia in human umbilical vein endothelial cells. Eur J Pharmacol 481: 33-40. (Pubitemid 37456784)
10. Ferrera N. 1999. Molecular and biological properties of vascular endothelial growth factor. J Mol Med 77: 527-543. (Pubitemid 29426311)
11. Folkman J. 1972. Anti-angiogenesis: new concept for therapy of solid tumors. Ann Surg 175: 409-416.
12. Folkman J. 1995. Seminars in medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med 333: 1757-1763.
13. Fong TA, Shawver LK, Sun L et al. 1995. SU5416 is a potent and selective inhbitor of the vascular endothelial growth factor receptor (Flk/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. Cancer Res 59: 99-106. (Pubitemid 29062964)
14. Fulton D, Gratton JP, McCabe TJ et al. 1999. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399(6736): 597-601. (Pubitemid 29279181)
15. Gao D, Song J, Hu J, Lin J et al. 2005. Angiogenesis promoting effects of Chinese herbal medicine for activating blood circulation to remove stasis on chick embryo chorio-allantoic membrane. Zhongguo Zhong Xi Yi Jie He Za Zhi 25: 912-915.
16. Gao QT, Choi RC, Cheung AW et al. 2007. Danggui buxue tang - a Chinese herbal decoction activates the phosphorylations of extracellular signal-regulated kinase and estrogen receptor alpha in cultured MCF-7 cells. FEBS Lett 581: 233-240.
17. Goliqorsky MS, Li H, Brodsky S, Chen J. 2002. Relationships between caveolae and eNOS: everything in proximity and the proximity of everything. Am J Physiol Renal Physiol 283: F1-F10. (Pubitemid 34680466)
18. Harris MB, Ju H, Venema VJ et al. 2001. Reciprocal phosphorylation and regulation of endothelial nitric-oxide synthase in response to bradykinin stimulation. J Biol Chem 276: 16587-16591. (Pubitemid 37391712)
19. Holash J, Wiegand SJ, Yancopoulos GD. 1999. New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 18: 5356-5362. (Pubitemid 29462372)
20. Isner JM, Asahara T. 1998. Therapeutic angiogenesis. Front Biosci 3: e49-e69.
21. Ji ZN, Zhao WY, Liao GR et al. 2006. In vitro estrogenic activity of formononetin by two bioassay systems. Gynecol Endocrinol 22: 578-584.
22. Kim C, Ha H, Lee JH, Kim JS, Song K, Park SW. 2003. Herbal extract prevents bone loss in ovariectomized rats. Arch Pharm Res 26: 917-924.
23. Kone BC. 2000. Protein-protein interactions controlling nitric oxide synthases. Acta Physiol Scand 168: 27-31. (Pubitemid 30128664)
24. Lam HW, Lin HC, Lao SC et al. 2008. The angiogenic effects of Angelica sinensis extract on HUVEC in vitro and zebrafish in vivo. J Cell Biochem 103: 195-211.
25. Lei H, Wang B, Li WP, Yang Y, Zhou AW, Chen MZ. 2003a. Anti-aging effect of astragalosides and its mechanism of action. Acta Pharmacol Sin 24: 230-234. (Pubitemid 36286009)
26. Lei Y, Wang JH, Chen KJ. 2003b. Comparative study on angiogenesis effect of Astragalus membranaceus and Angelica sinensis in chick embryo choriollantoic membrane. Zhongguo Zhong Yao Za Zhi 28: 876-878. (Pubitemid 41296131)
27. Li HB, Ge YK, Zhang L, Zheng XX. 2006. Astragaloside IV improved barrier dysfunction induced by acute high glucose in human umbilical vein endothelial cells. Life Sci 79: 1186-1193. (Pubitemid 44128584)
28. Ma XQ, Duan JA, Zhu DY, Dong, TT, Tsim KW. 2000. Species identification of Radix Astragali (Huangqi) by DNA sequence of its 5S-rRNA spacer domain. Phytochemistry 54: 363-368.
29. Ma XQ, Shi Q, Duan JA, Dong TT, Tsim KW. 2002. Chemical analysis of Radix Astragali (Huangqi) in China: a comparison with its adulterants and seasonal variations. J Agric Food Chem 50: 4861-4866. (Pubitemid 34856156)
30. Merchan JR, Chan B, Kale S, Schnipper LE, Sukhatme VP. 2003. In vitro and in vivo induction of antiangiogenic activity by plasminogen activators and captopril. J Natl Cancer Inst 95: 388-399.
31. Morales-Ruiz M, Lee MJ, Zonllner S et al. 2001. Sphingosine 1-phosphate activates Akt, nitric oxide production, and chemotaxis through a Gi protein/phosphoinositide 3-kinase pathway in endothelial cells. J Biol Chem 276: 19672-19677. (Pubitemid 37411309)
32. Navarrete A, Arrieta J, Terrones L, Abou-Gazar H, Calis I. 2005. Gastroprotective effect of Astragaloside IV: role of prostaglandins, sulfhydryls and nitric oxide. J Pharm Pharmacol 57: 1059-1064. (Pubitemid 41039842)
33. Park JE, Chen HH, Winer J, Houck KA, Ferrara N. 1994. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J Biol Chem 269: 25646-25654. (Pubitemid 24982909)
34. Pharmacopoeia of P. R. China Volume I. 2005. The State Pharmacopoeial Commission. Chemical Industry Press: Beijing, 212-213.
35. Risau W. 1997. Mechanisms of angiogenesis. Nature 386(6626): 671-674.
36. Sato Y, Rifkin DB. 1988. Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis. J Cell Biol 107: 1199-1205.
37. Sengupta S, Toh SA, Sellers LA et al. 2004. Modulating angiogenesis: the yin and the yang in ginseng. Circulation 110: 1219-1225. (Pubitemid 39202336)
38. Shalaby F, Rossant J, Yamaguchi TP et al. 1995. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376: 62-66.
39. Shen P, Liu MH, Ng TY, Chan YH, Yong EL. 2006. Differential effects of isoflavones, from Astragalus membranaceus and Pueraria thomsonii, on the activation of PPARalpha, PPARgamma, and adipocyte differentiation in vitro. J Nutr 136: 899-905.
40. Song ZH, Ji ZN, Lo CK et al. 2004. Chemical and biological assessment of a traditional Chinese herbal decoction prepared from Radix astragali and Radix Angelicae sinensis: orthogonal array design to optimize the extraction of chemical constituents. Planta Med 22: 122-127.
41. Tanimoto T, Jin ZG, Berk BC. 2002. Transactivation of vascular endothelial growth factor (VEGF) receptor Flk-1/KDR is involved in sphingosine 1-phosphate-stimulated phosphorylation of Akt and endothelial nitric-oxide synthase (eNOS). J Biol Chem 277: 42997-43001. (Pubitemid 35285679)
42. Urbich C, Dimmeler S. 2005. Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors. Kidney Int 67: 1672-1676. (Pubitemid 40577698)
43. Wang P, Zhang Z, Ma X et al. 2003. HDTIC-1 and HDTIC-2, two compounds extracted from Astragali Radix, delay replicative senescence of human diploid fibroblasts. Mech Ageing Dev 124: 1025-1034. (Pubitemid 37500828)
44. Wu Y, Zhu B. 2001. Effect of danggui buxue decoction on proliferation and expression of intercellular adhesion molecule-1 in human umbilical vein endothelial cells. Hua Xi Y Ke Da Xue Xue Bao 32: 593-595. (Pubitemid 33138935)
45. Yin X, Zhang Y, Wu H et al. 2004. Protective effects of Astragalus saponin I on early stage of diabetic nephropathy in rats. J Pharmacol Sci 95: 256-266. (Pubitemid 38899696)
46. Yu J, Zhang Y, Sun S et al. 2006. Inhibitory effects of astragaloside IV on diabetic peripheral neuropathy in rats. Can J Physiol Pharmacol 84: 579-587. (Pubitemid 44605721)
47. Zhang BQ, Hu SJ, Qiu LH et al. 2007a. Effects of Astragalus membranaceus and its main components on the acute phase endothelial dysfunction induced by homocysteine. Vasc Pharmacol 46: 278-285.
48. Zhang C, Wang XH, Zhong MF et al. 2007b. Mechanisms underlying vasorelaxant action of astragaloside IV in isolated rat aortic rings. Clin Exp Pharmacol Physiol 34: 387-392. (Pubitemid 46494462)
49. Zhang WD, Zhang C, Wang XH et al. 2006a. Astragaloside IV dilates aortic vessels from normal and spontaneously hypertensive rats through endothelium-dependent and endothelium-independent ways. Planta Med 72: 621-626.
50. Zhang WJ, Hufnagl P, Binder BR, Wojta J. 2003. Antiinflammatory activity of astragaloside IV is mediated by inhibition of NF-kappaB activation and adhesion molecule expression. Thromb Haemost 90: 904-914. (Pubitemid 37427861)
51. Zhang YW, Xie D, Xia B, Zhen RT, Liu IM, Cheng JT. 2006b. Suppression of transforming growth factor-beta1 gene expression by Danggui buxue tang, a traditional Chinese herbal preparation, in retarding the progress of renal damage in streptozotocin-induced diabetic rats. Horm Metab Res 38: 82-88.